Drugs India Pvt Ltd
About Drugs India Pvt Ltd
Data last updated:
Drugs India Pvt Ltd is a private limited company based in Guwahati, Assam, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 11 December 1973 and has been in existence for over 53 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24232AS1973PTC001457. Its GSTIN is 18AACCD1022E1ZC (Assam). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹12.2 Lakh. It is led by directors Jagat Chandra Hazarika and Amitabh Hazarika.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 2 2nd Bye Lane Lakhinagar Rg Baruah Road, Guwahati, Assam, India – 781005.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.8 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹48,275 (net margin -26.9%) and EBITDA of ₹66,191 (EBITDA margin 36.8%). Revenue has declined at a compounded annual rate (CAGR) of 47% over three years and 52% over five years.
The company is associated with 1 brand: Drugs India. Court records list 12 cases involving the company, including 10 filed by the company and 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Drugs India Pvt Ltd's registered office is in Guwahati, Assam. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No. 2 2nd Bye Lane Lakhinagar Rg Baruah Road, Guwahati, Assam, India – 781005
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Drugs India Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Drugs India operates one associated brand: Drugs India. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as a distributor of generic pharmaceutical drugs. | drugsindia.in |
Business activity
The main business activity of Drugs India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Drugs India Pvt Ltd
FY 2025 filings availableDrugs India Pvt Ltd reported revenue of ₹1.8 Lakh (up 14536% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 52% over five years. EBITDA rose 121% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹66,191 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹48,275 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 36.8% | ||||
| Net Profit Margin | -26.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Drugs India Pvt Ltd, buy the company report.
Board of directors of Drugs India Pvt Ltd
Drugs India has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagat Chandra Hazarika | Director | 01 Mar 2005 | 21 Years 7 Months | Current |
| Amitabh Hazarika | Director | 10 Jan 2005 | 21 Years 9 Months | Current |
Auditor
Drugs India Pvt Ltd is audited by SANJAY R JAIN & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY R JAIN & CO | FY 2021 | 327439E |
Shareholding
The shareholding of Drugs India Pvt Ltd is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Drugs India Pvt Ltd, buy the company report.
Legal cases
Drugs India Pvt Ltd has 12 court cases on record: 10 filed by Drugs India, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 1 | 0 |
| High courts | 5 | 1 | 0 |
| NCLT | 2 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Court case (C.A.(CAA)) | Filed by the company | Disposed |
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
| High Court, UTTARPRADESH | Writ petition | Filed by the company against Union of India and 6 Others | Disposed |
| District court, Indore, Madhya Pradesh | Court case (UN CR) | Filed by the company against M/S G.G. Pharma Through Vikanshu Jain and 3 others | Disposed |
| District court, Shahdara, Delhi | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Drugs India Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Drugs India Pvt Ltd was last rated by Care on 17 Jun 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 17 Jun 2022 |
To see the full credit ratings and regulatory alerts of Drugs India Pvt Ltd, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Drugs India Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Drugs India has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AACCD1022E1ZC | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Drugs India Pvt Ltd, buy the company report.
Recent activity
Drugs India Pvt Ltd has 6 board changes on record since 2005: 2 appointments and 4 cessations. The latest: Debajit Kumar Baruah ceased to be Director on 08 Jun 2020.
Frequently asked questions
Drugs India is an active private limited company based in Guwahati, Assam, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 11 December 1973 (53+ years old) and is registered under CIN U24232AS1973PTC001457.
Drugs India has 2 current directors:
- Jagat Chandra Hazarika - Director
- Amitabh Hazarika - Director
The latest financial statements of Drugs India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Drugs India is 18AACCD1022E1ZC, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Drugs India is U24232AS1973PTC001457. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Drugs India has 12 court cases on record: 10 filed by the company and 2 filed against it. Most are in the district courts.
Drugs India was incorporated on 11 December 1973, making it 53+ years old. It is registered with the Registrar of Companies, Guwahati.
Debajit Kumar Baruah ceased to be Director on 08 Jun 2020. Dizen Phukan ceased to be Director on 08 Jun 2020. Mallika Hazarika ceased to be Director on 07 Jun 2019. Drugs India has 6 board changes on record in total.
The registered office of Drugs India is at House No. 2 2nd Bye Lane Lakhinagar Rg Baruah Road, Guwahati, Assam, India – 781005.
Drugs India operates in the healthcare industry, in the medical equipment retail and distribution segment.